A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

Inclusion Criteria: * Diagnosis of painful, distal, symmetrical, sensorimotor polyneuropathy which is due to diabetes * Stable glycemic control for at least 6 months prior to screening visit * Average Numeric Pain Rating Scale (NPRS) score over the last 24 hours of \>4 at the screening and the baseline visit Exclusion Criteria: * Primary pain associated with PDPN in the ankles or above * Pain that could not be clearly differentiated from, or conditions that might interfere with, the assessment of PDPN * Significant pain (moderate or above) of an etiology other than PDPN, that may interfere with judging PDPN-related pain * Female subjects of childbearing potential must have a negative serum or urine pregnancy test at enrollment and must agree to maintain highly effective birth control during the study. * Hypersensitivity to capsaicin (i.e., chili peppers or over-the-counter \[OTC\] capsaicin products), any QUTENZA excipients, Eutectic Mixture of Local Anesthetics( EMLA) ingredients or adhesives